Altimmune ((ALT)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Altimmune painted a largely positive picture, with the company showcasing ...

Since the Group of Twenty’s foundational Pittsburgh conference in 2009, progress toward its goal of strong, sustainable, balanced, and inclusive growth has been modest. While G20 economies have shown ...

Sustainable success comes from intentional, steady growth — not hastily scaling up or chasing short-term gains. High-performing entrepreneurs focus on fundamentals like brand clarity, reliable systems ...

The current landscape for GI practices is defined by a tension between increasing external pressure and stagnating internal capacity. A recent Becker’s article highlighted persistent challenges: ...

Benjamin Franklin’s famous quote, “Without continual growth and progress, such words as improvement, achievement, and success ...

Yogesh Gupta, CEO, began by highlighting another outstanding quarter, stating the company "outperformed on every metric as our business benefited from our customers' investments in their AI ...

I reiterate my buy rating for Amplitude stock, expecting mid-teens revenue growth and a 20% upside to the share price. AMPL's enterprise sales strategy is driving significant ARR growth, with ...